Top Markets
Coin of the day
Annovis Bio, Inc. Annovis Bio, Inc.

Annovis Bio, Inc.

ANVS
Peringkat dalam Saham #23205
Annovis Bio, Inc. is a clinical-stage biopharmaceutical company focused on... Annovis Bio, Inc. is a clinical-stage biopharmaceutical company focused on pioneering treatments for neurodegenerative disorders. The firm's flagship drug, Buntanetap, an oral medication, has successfully advanced through Phase 2a clinical trials for Alzheimer's and Parkinson's diseases. This compound is also currently being evaluated in clinical studies for Alzheimer's disease in individuals with Down Syndrome, as well as for various other chronic neurodegenerative conditions. Beyond Buntanetap, Annovis Bio is developing ANVS405 to offer protection against traumatic brain injury and stroke. Additionally, ANVS301 is progressing through Phase I clinical trials, aiming to enhance cognitive capabilities in the later stages of Alzheimer's disease and broader dementia. The company was founded in 2008 and operates out of Berwyn, Pennsylvania.
Harga Saham
$1.81
Terakhir disinkronkan: 2026-08-21
Kapitalisasi Pasar
$77.00M
Perubahan (1 hari)
1.30%
Perubahan (1 tahun)
-23.63%
Negara
US
Perdagangan Annovis Bio, Inc. (ANVS)

Kategori

Riwayat harga saham Annovis Bio, Inc. (ANVS)
Harga penutupan tertinggi: $1.82 pada 2026-08-01

Harga penutupan terendah: $7.71 pada 2020-01-01
Riwayat harga saham Annovis Bio, Inc. dari 2020 hingga 2026
Performa harga saham tahunan
Tahun Performa
2026 (TTM) -38.81%
2025 -26.28%
2024 -55.51%
2023 0.70%
2022 -41.39%
2021 233.32%
2020 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH